The pharmacokinetics of meropenem and piperacillin-tazobactam during sustained low efficiency haemodiafiltration (SLED-HDF)

ConclusionsThe pharmacokinetic data obtained from this pilot study demonstrate significant quantities of meropenem and piperacillin are removed during a SLED-HDF session. This may lead to subtherapeutic concentrations of piperacillin and meropenem over the duration of HDF session.Trial registrationAustralasian Clinical Trials Registry Network (ACTRN12616000078459)
Source: European Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Source Type: research